Aigen Investment Management, LP Taro Pharmaceutical Industries LTD Transaction History

Aigen Investment Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$54.4 - $73.42 $18,550 - $25,036	-341 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$54.41 - $68.2 $336,308 - $421,544	-6,181 Reduced 94.77%	341 $19,000
Q2 2020 Aug 10, 2020	BUY	$61.66 - $70.16 $205,574 - $233,913	3,334 Added 104.58%	6,522 $434,000
Q1 2020 May 08, 2020	BUY	$59.35 - $88.73 $38,518 - $57,585	649 Added 25.56%	3,188 $195,000
Q4 2019 Feb 04, 2020	BUY	$74.18 - $97.92 $188,343 - $248,618	2,539 New	2,539 $223,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.